Global Partners LP (GLP)
Global Partners LP (GLP) is a North American energy company engaged in the wholesale distribution of motor fuels, transportation, and storage of petroleum products. Founded in the 1930s, it operates a network of fueling stations, terminals, and related infrastructure, focusing on distribution throughout the northeastern United States. The company also offers refined petroleum products, including gasoline, diesel, and other motor fuels, serving a variety of commercial, industrial, and retail customers.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 14, 2025 | $0.75 | 2025-08-08 | 2025-08-08 |
| May 15, 2025 | $0.74 | 2025-05-09 | 2025-05-09 |
| February 14, 2025 | $0.74 | 2025-02-10 | 2025-02-10 |
| November 14, 2024 | $0.73 | 2024-11-08 | 2024-11-08 |
| August 14, 2024 | $0.72 | 2024-08-08 | 2024-08-08 |
Dividends Summary
- Global Partners LP has issued 79 dividend payments over the past 19 years
- The most recent dividend was paid 37 days ago, on August 14, 2025
- The highest dividend payed out to investors during this period was $0.9375 per share
- The average dividend paid during this period was $0.55 per share.
Company News
Our first-ever twin bill.
Global Partners (GLP) beat the Zacks Consensus Estimate for earnings in two of the last four quarters and missed in the other two, resulting in an earnings surprise of 5.9%, on average.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Raymond James raised Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) price target from $12 to $15. Raymond James analyst Rahul Sarugaser upgraded the stock from Outperform to Strong Buy. Fusion Pharmaceuticals shares jumped 16.7% to close at $7.97 on Tuesday. See how other analysts view this stock. BTIG boosted the price target for Organogenesis Holdings Inc. (NASDAQ: ORGO) from $4 to $6. BTIG analyst Ryan Zimmerman maintained a Buy rating. Organogenesis shares gained 0.3% to close at $3.97 on Tuesday. See how other analysts view this stock. Canaccord Genuity boosted the price target for Aspen Aerogels, Inc. (NYSE: ASPN) from $13 to $17. Canaccord Genuity analyst George Gianarikas maintained a Buy rating. Aspen ...Full story available on Benzinga.com
Income investing can help you achieve financial freedom. Check out a CEF and a fixed-income investment pick trading at discounts and offering attractive yields.
